Home › NDC Lookup › RxCUI directory › RxCUI 722120

Ambrisentan 10 MG Oral Tablet [Letairis] — RxCUI 722120

RxNorm drug concept · Semantic branded drug
RxCUI 722120 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI722120
Official nameAmbrisentan 10 MG Oral Tablet [Letairis]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLetairis 10 MG Oral Tablet
FDA products mapped2
Package NDCs mapped10
Reported Medicaid activity (SDUD)1,535 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ambrisentan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ambrisentan won't cure PAH, but it can make a real difference in how you feel and function. It works by blocking a protein called ET-1 that causes the blood vessels in your lungs t...
  • What exactly does ambrisentan do, and will it cure my PAH?
  • Good news — food doesn't affect how well your body absorbs ambrisentan, so you can take it with or without a meal, whichever works best for your routine. Pick a time of day you can...
  • Can I take ambrisentan with food, and does it matter what time of day I take it?
📖 Read our full Ambrisentan guide →

🕸️ Concept Web — How Ambrisentan 10 MG Oral Tablet [Letairis] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ambrisentan 10 MG Oral Tablet [Letairis] RxCUI 722120

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ambrisentan 358274
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Letairis 722117
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ambrisentan Oral Tablet 722115
    • Ambrisentan Oral Product 1157135
    • Ambrisentan Pill 1157136
    • Ambrisentan Oral Tablet [Letairis] 722119
    • Letairis Oral Product 1166063
    • Letairis Pill 1166064
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ambrisentan 10 MG Oral Tablet SCD · 722116
  • Ambrisentan 10 MG SCDC · 722114
  • Ambrisentan Oral Tablet SCDF · 722115
  • Ambrisentan Oral Product SCDG · 1157135
  • Ambrisentan Pill SCDG · 1157136

Brand-Name Concepts

  • Ambrisentan 10 MG [Letairis] SBDC · 722118
  • Ambrisentan Oral Tablet [Letairis] SBDF · 722119
  • Letairis Oral Product SBDG · 1166063
  • Letairis Pill SBDG · 1166064
  • Letairis BN · 722117

📦 FDA Products & Package NDCs

2 products · 10 package NDCs
10 package NDCs map to RxCUI 722120 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61958-0801-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0801-1) Letairis Gilead Sciences, Inc. 2007-06-15
61958-0801-02 3 BLISTER PACK in 1 CARTON (61958-0801-2) / 10 TABLET, FILM... Letairis Gilead Sciences, Inc. 2007-06-15
61958-0801-03 1 BLISTER PACK in 1 CARTON (61958-0801-3) / 10 TABLET, FILM... Letairis Gilead Sciences, Inc. 2007-06-15
61958-0801-04 1 BLISTER PACK in 1 CARTON (61958-0801-4) / 10 TABLET, FILM... Letairis Gilead Sciences, Inc. 2007-06-15
61958-0801-05 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0801-5) Letairis Gilead Sciences, Inc. 2007-06-15
61958-0801-06 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0801-6) Letairis Gilead Sciences, Inc. 2007-06-15
61958-0802-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0802-1) Letairis Gilead Sciences, Inc. 2007-06-15
61958-0802-02 3 BLISTER PACK in 1 CARTON (61958-0802-2) / 10 TABLET, FILM... Letairis Gilead Sciences, Inc. 2007-06-15
61958-0802-03 1 BLISTER PACK in 1 CARTON (61958-0802-3) / 10 TABLET, FILM... Letairis Gilead Sciences, Inc. 2007-06-15
61958-0802-05 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0802-5) Letairis Gilead Sciences, Inc. 2007-06-15
Observed labelers: Gilead Sciences, Inc. (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.